These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2172121)

  • 1. Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary.
    Kaern J; Trope C; Kjorstad KE; Abeler V; Pettersen EO
    Gynecol Oncol; 1990 Sep; 38(3):452-7. PubMed ID: 2172121
    [No Abstract]   [Full Text] [Related]  

  • 2. Borderline ovarian tumors.
    Baak JP; van Diest PJ
    Am J Surg Pathol; 1998 Jul; 22(7):904-7. PubMed ID: 9669355
    [No Abstract]   [Full Text] [Related]  

  • 3. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
    Guerrieri C; Högberg T; Wingren S; Fristedt S; Simonsen E; Boeryd B
    Cancer; 1994 Oct; 74(8):2329-40. PubMed ID: 7922984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protooncogene amplification and tumor ploidy in human ovarian neoplasms.
    Sasano H; Garrett CT; Wilkinson DS; Silverberg S; Comerford J; Hyde J
    Hum Pathol; 1990 Apr; 21(4):382-91. PubMed ID: 1969381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary.
    Kigawa J; Minagawa Y; Ishihara H; Kanamori Y; Terakawa N
    Cancer; 1993 Aug; 72(3):804-8. PubMed ID: 8334634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucin-producing pancreatic tumors: a study of nuclear DNA content by flow cytometry.
    Murakami Y; Yokoyama T; Kodama T; Takesue Y; Okita M; Nakamitsu A; Imamura Y; Santo T; Tsumura H; Miyamoto K
    Surg Today; 1993; 23(6):491-5. PubMed ID: 8395265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma.
    Skirnisdóttir I; Sorbe B; Karlsson M; Seidal T
    Int J Oncol; 2001 Dec; 19(6):1295-302. PubMed ID: 11713603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
    Enomoto T; Weghorst CM; Inoue M; Tanizawa O; Rice JM
    Am J Pathol; 1991 Oct; 139(4):777-85. PubMed ID: 1656759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DNA content of ovarian tumors: correlation to established prognostic parameters and clinical course].
    Kristen P; Kaesemann H; Dostert M; Caffier H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():204-5. PubMed ID: 8118271
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary.
    Klemi PJ; Joensuu H; Salmi T
    Cancer; 1990 Mar; 65(5):1189-93. PubMed ID: 2302667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of cell DNA content in early-stage ovarian cancer (FIGO stages I and II/A) by means of automatic image cytometry.
    Wagner TM; Adler A; Sevelda P; Assmann I; Knepflé CF; Czerwenka K; Heinzl H; Ploem-Zaaijer JJ
    Int J Cancer; 1994 Jan; 56(2):167-72. PubMed ID: 8314296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of S-phase fraction as measured by DNA flow cytometry in gynecologic malignancies.
    Strang P; Stendahl U; Tribukait B
    Ann N Y Acad Sci; 1993 Mar; 677():354-63. PubMed ID: 8494220
    [No Abstract]   [Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
    Karaburun S; Karaveli S; Peştereli HE; Simsek T; Sargin CF
    Adv Clin Path; 2001 Jan; 5(1-2):3-9. PubMed ID: 11753828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
    Mok SC; Bell DA; Knapp RC; Fishbaugh PM; Welch WR; Muto MG; Berkowitz RS; Tsao SW
    Cancer Res; 1993 Apr; 53(7):1489-92. PubMed ID: 8384077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
    Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
    Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase cytogenetic analysis of mucinous ovarian neoplasms.
    Diebold J; Siegert S; Baretton GB; Suchy B; Meier W; Haas CJ; Löhrs U
    Lab Invest; 1997 May; 76(5):661-70. PubMed ID: 9166285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
    Lage JM; Weinberg DS; Huettner PC; Mark SD
    Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.